![](/img/cover-not-exists.png)
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
Fernandez-Plana, Julen, Pericay, Carlos, Quintero, Guillermo, Alonso, Vicente, Salud, Antonieta, Mendez, Miguel, Salgado, Mercedes, Saigi, Eugeni, Cirera, LuisVolume:
14
Year:
2014
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/1471-2407-14-865
File:
PDF, 381 KB
english, 2014